Debilitating long COVID with dysautonomia and PEM, now somewhat better on a GLP-1
- Condition
- Long COVID
- At worst
- Moderate (mostly housebound)
- Ill before improving or writing
- 2.5 years
- Last post
- Sep 2024
In their words
- Condition: Long COVID
My long COVID went from debilitating to manageable.
In context ↗ - At worst: Moderate
I've been sick for three years and had dysautonomia, cognitive issues, PEM, joint pain, and impaired cardiovascular health.
In context ↗ - Now: Somewhat better
My long COVID went from debilitating to manageable.
In context ↗ - Began after: COVID
My long COVID went from debilitating to manageable.
In context ↗
Summary
Oak 75345 had long COVID for three years, with dysautonomia, cognitive issues, PEM, joint pain and impaired cardiovascular health. In 2024 they started a GLP-1 medication; full-body inflammation cleared, cognitive and joint problems resolved, dysautonomia lessened, and their illness went from debilitating to manageable. Six months in they were still improving, though PEM and breathing issues remained; they expected to stay on the lowest dose.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- GLP-1 medication · Helped a lot
Within a month I felt significantly better. Now I'm six months in and still improving.
In context ↗
Approaches: GLP-1 drugs
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, with time counted from when the illness began. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| onset | long COVID onset; debilitating illness with dysautonomia, cognitive issues, PEM, joint pain and cardiovascular impairmentI've been sick for three years and had dysautonomia, cognitive issues, PEM, joint pain, and impaired cardiovascular health.In context ↗ | Moderate | |
| 2.5 y | started GLP-1; full-body inflammation gone, cognitive and joint issues resolved, less dysautonomiaI did see a massive improvement when I went on GLP-1 medicationIn context ↗ | Mild | GLP-1 drugs (unspecified) |
| 2024-09-06 | six months on GLP-1, still improving; PEM and breathing issues remainNow I'm six months in and still improving.In context ↗ | Mild | GLP-1 drugs (unspecified) |
Symptoms mentioned
Their words about their symptoms
- Post-exertional malaise
Still get PEM and have breathing issues.
In context ↗ - Brain fog
cognitive issues are done
In context ↗ - POTS & dysautonomia
Less dysautonomia.
In context ↗ - Pain & fibromyalgia
the joint pain started coming back
In context ↗ - Breathlessness
have breathing issues
In context ↗ - Heart symptoms & palpitations
impaired cardiovascular health
In context ↗
Ask Miruvor AI
Similar stories
-
Severe ME/CFS, housebound and often bedbound; walking better after physio, then relapsed
Pebble 29054, in the UK, has suspected ME/CFS and describes a decline from mild to severe after NHS GET/CBT and exercise, now housebound and often bedbound with crashes, sleep disruption, headaches, dizziness, GI/IBS and electrolyte problems. A private…
-
Moderate ME/CFS with pain and brain fog, somewhat better with pacing and a GLP-1
Ill for several years with suspected ME/CFS, fibromyalgia, hypersomnia and celiac, this US patient described themselves as moderate rather than severe and never fully bedbound, with PEM, pain, brain fog and flu-like symptoms. Pacing evened out their week and…
-
Not enough detail to draw a path
POTS, chest pain and lung clots after COVID, much better with water and salt
After COVID in late November 2020, Creek 56336 developed POTS, chest pain, muscle spasms and lung clots, and has anxiety and trouble sleeping. She stayed on anticoagulants after symptoms returned within two weeks of stopping. She lists water, salt, quitting…
-
Not enough detail to draw a path
Unable to speak nearly two years with ME/CFS, now somewhat better on GLP-1
Cove 77840 was in a dark room, unable to speak, for nearly two years and needed their mother to care for them; they also had thoughts of ending their life. Over the last four months they improved very slowly, which they attributed to starting a GLP-1 drug,…